Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Cancer Research | Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer Based on Circulating Cell-Free DNA Methylation Profiling
2026-09-20
【Frontier Express】Drugs | The Dual Roles of BAFF in Systemic Lupus Erythematosus: From Pathogenic Factor to Key Regulator of Regulatory B Cells
2026-09-20
【Frontier Express】Nature Communications | SBAGA Study: Sintilimab Combined with IBI305 and Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
2026-09-19
【Frontier Express】Nature | Modular in vivo antibody–ADC click to reverse drug resistance in tumours
2026-09-19
【Frontier Express】Journal of Hematology & Oncology | Long-term follow-up study of anti-GDF-15 antibody visugromab combined with nivolumab for anti-PD-1/PD-L1 resistant solid tumors
2026-09-18
【Frontier Express】Nature Medicine | Phase 1 Trial of Englumafusp Alfa in Combination with Glofitamab for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
2026-09-18
【Frontier Express】Advanced Science | Lilrb4a Suppression Reprograms Microglia via PPAR Pathway to Alleviate APOE4-Associated Amyloid Pathology
2026-09-17






